Gossamer Bio, Inc.
GOSS· Nasdaq
GOSSGossamer Bio, Inc.
Filed May 14, 2019 · 10-Q · 44 days after period end · 0001564590-19-018973
| Metric | Q1 2019 | Q1 2018 |
|---|---|---|
| Net Income | -$32.61M | -$26.04M |
| EPS Diluted | -$0.90 | -$4.31 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Gossamer Bio, Inc. · CIK 1728117 · Engraved from SEC EDGAR
ended Mar 31, 2019 · filed May 14, 2019 · 44 d after period end
